China Anti-malarial Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Anti-malarial Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Anti-malarial Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Anti-malarial Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Ipca Laboratories Ltd

    • Bayer AG

    • Pfizer, Inc

    • Novartis AG

    • GlaxoSmithKline Plc

    • Merck KGaA

    • F Hoffmann-La Roche AG

    • Ranbaxy Laboratories

    • Zydus Cadila

    • Alvizia Health Care

    By Type:

    • Quinine

    • Chloroquine

    • Pyrimethamine

    • Amodiaquine

    • Proguanil

    • Mefloquine

    • Sulfonamide

    • Other

    By End-User:

    • Falciparum Malaria

    • Vivax Malaria

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-malarial Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Anti-malarial Drugs Market Size and Growth Rate of Quinine from 2016 to 2027

    • 1.3.2 China Anti-malarial Drugs Market Size and Growth Rate of Chloroquine from 2016 to 2027

    • 1.3.3 China Anti-malarial Drugs Market Size and Growth Rate of Pyrimethamine from 2016 to 2027

    • 1.3.4 China Anti-malarial Drugs Market Size and Growth Rate of Amodiaquine from 2016 to 2027

    • 1.3.5 China Anti-malarial Drugs Market Size and Growth Rate of Proguanil from 2016 to 2027

    • 1.3.6 China Anti-malarial Drugs Market Size and Growth Rate of Mefloquine from 2016 to 2027

    • 1.3.7 China Anti-malarial Drugs Market Size and Growth Rate of Sulfonamide from 2016 to 2027

    • 1.3.8 China Anti-malarial Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Anti-malarial Drugs Market Size and Growth Rate of Falciparum Malaria from 2016 to 2027

    • 1.4.2 China Anti-malarial Drugs Market Size and Growth Rate of Vivax Malaria from 2016 to 2027

    • 1.4.3 China Anti-malarial Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Anti-malarial Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Anti-malarial Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of Quinine

    • 3.4.2 Market Size and Growth Rate of Chloroquine

    • 3.4.3 Market Size and Growth Rate of Pyrimethamine

    • 3.4.4 Market Size and Growth Rate of Amodiaquine

    • 3.4.5 Market Size and Growth Rate of Proguanil

    • 3.4.6 Market Size and Growth Rate of Mefloquine

    • 3.4.7 Market Size and Growth Rate of Sulfonamide

    • 3.4.8 Market Size and Growth Rate of Other

    4 Segmentation of Anti-malarial Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Anti-malarial Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Anti-malarial Drugs in Falciparum Malaria

    • 4.4.2 Market Size and Growth Rate of Anti-malarial Drugs in Vivax Malaria

    • 4.4.3 Market Size and Growth Rate of Anti-malarial Drugs in Others

    5 Market Analysis by Regions

    • 5.1 China Anti-malarial Drugs Production Analysis by Regions

    • 5.2 China Anti-malarial Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Anti-malarial Drugs Landscape Analysis

    • 6.1 North China Anti-malarial Drugs Landscape Analysis by Major Types

    • 6.2 North China Anti-malarial Drugs Landscape Analysis by Major End-Users

    7 Central China Anti-malarial Drugs Landscape Analysis

    • 7.1 Central China Anti-malarial Drugs Landscape Analysis by Major Types

    • 7.2 Central China Anti-malarial Drugs Landscape Analysis by Major End-Users

    8 South China Anti-malarial Drugs Landscape Analysis

    • 8.1 South China Anti-malarial Drugs Landscape Analysis by Major Types

    • 8.2 South China Anti-malarial Drugs Landscape Analysis by Major End-Users

    9 East China Anti-malarial Drugs Landscape Analysis

    • 9.1 East China Anti-malarial Drugs Landscape Analysis by Major Types

    • 9.2 East China Anti-malarial Drugs Landscape Analysis by Major End-Users

    10 Northeast China Anti-malarial Drugs Landscape Analysis

    • 10.1 Northeast China Anti-malarial Drugs Landscape Analysis by Major Types

    • 10.2 Northeast China Anti-malarial Drugs Landscape Analysis by Major End-Users

    11 Southwest China Anti-malarial Drugs Landscape Analysis

    • 11.1 Southwest China Anti-malarial Drugs Landscape Analysis by Major Types

    • 11.2 Southwest China Anti-malarial Drugs Landscape Analysis by Major End-Users

    12 Northwest China Anti-malarial Drugs Landscape Analysis

    • 12.1 Northwest China Anti-malarial Drugs Landscape Analysis by Major Types

    • 12.2 Northwest China Anti-malarial Drugs Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Ipca Laboratories Ltd

      • 13.1.1 Ipca Laboratories Ltd Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Bayer AG

      • 13.2.1 Bayer AG Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Pfizer, Inc

      • 13.3.1 Pfizer, Inc Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Novartis AG

      • 13.4.1 Novartis AG Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 GlaxoSmithKline Plc

      • 13.5.1 GlaxoSmithKline Plc Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Merck KGaA

      • 13.6.1 Merck KGaA Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 F Hoffmann-La Roche AG

      • 13.7.1 F Hoffmann-La Roche AG Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Ranbaxy Laboratories

      • 13.8.1 Ranbaxy Laboratories Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Zydus Cadila

      • 13.9.1 Zydus Cadila Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Alvizia Health Care

      • 13.10.1 Alvizia Health Care Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Quinine from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Chloroquine from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Pyrimethamine from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Amodiaquine from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Proguanil from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Mefloquine from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Sulfonamide from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Falciparum Malaria from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Vivax Malaria from 2016 to 2027

    • Figure China Anti-malarial Drugs Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Anti-malarial Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Anti-malarial Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Anti-malarial Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Anti-malarial Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Anti-malarial Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Quinine

    • Figure Market Size and Growth Rate of Chloroquine

    • Figure Market Size and Growth Rate of Pyrimethamine

    • Figure Market Size and Growth Rate of Amodiaquine

    • Figure Market Size and Growth Rate of Proguanil

    • Figure Market Size and Growth Rate of Mefloquine

    • Figure Market Size and Growth Rate of Sulfonamide

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Anti-malarial Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Anti-malarial Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Falciparum Malaria

    • Figure Market Size and Growth Rate of Vivax Malaria

    • Figure Market Size and Growth Rate of Others

    • Table China Anti-malarial Drugs Production by Regions

    • Table China Anti-malarial Drugs Production Share by Regions

    • Figure China Anti-malarial Drugs Production Share by Regions in 2016

    • Figure China Anti-malarial Drugs Production Share by Regions in 2021

    • Figure China Anti-malarial Drugs Production Share by Regions in 2027

    • Table China Anti-malarial Drugs Consumption by Regions

    • Table China Anti-malarial Drugs Consumption Share by Regions

    • Figure China Anti-malarial Drugs Consumption Share by Regions in 2016

    • Figure China Anti-malarial Drugs Consumption Share by Regions in 2021

    • Figure China Anti-malarial Drugs Consumption Share by Regions in 2027

    • Table North China Anti-malarial Drugs Consumption by Types from 2016 to 2027

    • Table North China Anti-malarial Drugs Consumption Share by Types from 2016 to 2027

    • Figure North China Anti-malarial Drugs Consumption Share by Types in 2016

    • Figure North China Anti-malarial Drugs Consumption Share by Types in 2021

    • Figure North China Anti-malarial Drugs Consumption Share by Types in 2027

    • Table North China Anti-malarial Drugs Consumption by End-Users from 2016 to 2027

    • Table North China Anti-malarial Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure North China Anti-malarial Drugs Consumption Share by End-Users in 2016

    • Figure North China Anti-malarial Drugs Consumption Share by End-Users in 2021

    • Figure North China Anti-malarial Drugs Consumption Share by End-Users in 2027

    • Table Central China Anti-malarial Drugs Consumption by Types from 2016 to 2027

    • Table Central China Anti-malarial Drugs Consumption Share by Types from 2016 to 2027

    • Figure Central China Anti-malarial Drugs Consumption Share by Types in 2016

    • Figure Central China Anti-malarial Drugs Consumption Share by Types in 2021

    • Figure Central China Anti-malarial Drugs Consumption Share by Types in 2027

    • Table Central China Anti-malarial Drugs Consumption by End-Users from 2016 to 2027

    • Table Central China Anti-malarial Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Anti-malarial Drugs Consumption Share by End-Users in 2016

    • Figure Central China Anti-malarial Drugs Consumption Share by End-Users in 2021

    • Figure Central China Anti-malarial Drugs Consumption Share by End-Users in 2027

    • Table South China Anti-malarial Drugs Consumption by Types from 2016 to 2027

    • Table South China Anti-malarial Drugs Consumption Share by Types from 2016 to 2027

    • Figure South China Anti-malarial Drugs Consumption Share by Types in 2016

    • Figure South China Anti-malarial Drugs Consumption Share by Types in 2021

    • Figure South China Anti-malarial Drugs Consumption Share by Types in 2027

    • Table South China Anti-malarial Drugs Consumption by End-Users from 2016 to 2027

    • Table South China Anti-malarial Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South China Anti-malarial Drugs Consumption Share by End-Users in 2016

    • Figure South China Anti-malarial Drugs Consumption Share by End-Users in 2021

    • Figure South China Anti-malarial Drugs Consumption Share by End-Users in 2027

    • Table East China Anti-malarial Drugs Consumption by Types from 2016 to 2027

    • Table East China Anti-malarial Drugs Consumption Share by Types from 2016 to 2027

    • Figure East China Anti-malarial Drugs Consumption Share by Types in 2016

    • Figure East China Anti-malarial Drugs Consumption Share by Types in 2021

    • Figure East China Anti-malarial Drugs Consumption Share by Types in 2027

    • Table East China Anti-malarial Drugs Consumption by End-Users from 2016 to 2027

    • Table East China Anti-malarial Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure East China Anti-malarial Drugs Consumption Share by End-Users in 2016

    • Figure East China Anti-malarial Drugs Consumption Share by End-Users in 2021

    • Figure East China Anti-malarial Drugs Consumption Share by End-Users in 2027

    • Table Northeast China Anti-malarial Drugs Consumption by Types from 2016 to 2027

    • Table Northeast China Anti-malarial Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Anti-malarial Drugs Consumption Share by Types in 2016

    • Figure Northeast China Anti-malarial Drugs Consumption Share by Types in 2021

    • Figure Northeast China Anti-malarial Drugs Consumption Share by Types in 2027

    • Table Northeast China Anti-malarial Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast China Anti-malarial Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Anti-malarial Drugs Consumption Share by End-Users in 2016

    • Figure Northeast China Anti-malarial Drugs Consumption Share by End-Users in 2021

    • Figure Northeast China Anti-malarial Drugs Consumption Share by End-Users in 2027

    • Table Southwest China Anti-malarial Drugs Consumption by Types from 2016 to 2027

    • Table Southwest China Anti-malarial Drugs Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Anti-malarial Drugs Consumption Share by Types in 2016

    • Figure Southwest China Anti-malarial Drugs Consumption Share by Types in 2021

    • Figure Southwest China Anti-malarial Drugs Consumption Share by Types in 2027

    • Table Southwest China Anti-malarial Drugs Consumption by End-Users from 2016 to 2027

    • Table Southwest China Anti-malarial Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Anti-malarial Drugs Consumption Share by End-Users in 2016

    • Figure Southwest China Anti-malarial Drugs Consumption Share by End-Users in 2021

    • Figure Southwest China Anti-malarial Drugs Consumption Share by End-Users in 2027

    • Table Northwest China Anti-malarial Drugs Consumption by Types from 2016 to 2027

    • Table Northwest China Anti-malarial Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Anti-malarial Drugs Consumption Share by Types in 2016

    • Figure Northwest China Anti-malarial Drugs Consumption Share by Types in 2021

    • Figure Northwest China Anti-malarial Drugs Consumption Share by Types in 2027

    • Table Northwest China Anti-malarial Drugs Consumption by End-Users from 2016 to 2027

    • Table Northwest China Anti-malarial Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Anti-malarial Drugs Consumption Share by End-Users in 2016

    • Figure Northwest China Anti-malarial Drugs Consumption Share by End-Users in 2021

    • Figure Northwest China Anti-malarial Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Ipca Laboratories Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipca Laboratories Ltd

    • Figure Sales and Growth Rate Analysis of Ipca Laboratories Ltd

    • Figure Revenue and Market Share Analysis of Ipca Laboratories Ltd

    • Table Product and Service Introduction of Ipca Laboratories Ltd

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of Pfizer, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc

    • Figure Revenue and Market Share Analysis of Pfizer, Inc

    • Table Product and Service Introduction of Pfizer, Inc

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Company Profile and Development Status of F Hoffmann-La Roche AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche AG

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche AG

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche AG

    • Table Product and Service Introduction of F Hoffmann-La Roche AG

    • Table Company Profile and Development Status of Ranbaxy Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ranbaxy Laboratories

    • Figure Sales and Growth Rate Analysis of Ranbaxy Laboratories

    • Figure Revenue and Market Share Analysis of Ranbaxy Laboratories

    • Table Product and Service Introduction of Ranbaxy Laboratories

    • Table Company Profile and Development Status of Zydus Cadila

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Cadila

    • Figure Sales and Growth Rate Analysis of Zydus Cadila

    • Figure Revenue and Market Share Analysis of Zydus Cadila

    • Table Product and Service Introduction of Zydus Cadila

    • Table Company Profile and Development Status of Alvizia Health Care

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alvizia Health Care

    • Figure Sales and Growth Rate Analysis of Alvizia Health Care

    • Figure Revenue and Market Share Analysis of Alvizia Health Care

    • Table Product and Service Introduction of Alvizia Health Care


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.